About this Research Topic
Oral diseases are commonly caused by poor oral hygiene behavior and host-related environmental factors (e.g. oral microorganism, immune responses, general factors, obesity, smoking status, lifestyle, etc.). According to the WHO definition, oral health is “a state of being free from chronic mouth and facial pain, oral and throat cancer, oral infection and sores, periodontal (gum) disease, dental caries, tooth loss, and other diseases and disorders that limit an individual’s capacity in biting, chewing, smiling, speaking, and psycho-social well-being” and this is an important indicator of overall health.
As a result of the aging population worldwide, the number of people who need oral care has substantially increased. At the same time, the presence of systemic diseases forms a significant challenge for oral health care. The lengthening of the average life and the proportional increase of the elderly population has determined an increase in systemic diseases and polypathology. Pharmaceutical development is, on the one hand, strongly related to these changes. Therefore, developing good oral health (including better motivation, attitude or behavior) and positive host environmental factors through multidisciplinary cooperation will be of great help in enhancing the prevention and treatment outcome of oral disease, and significantly improve the quality of life. With the increasing elderly population, the treatment of oral diseases will also require new drugs, particularly for the treatment of oral manifestations of systemic pathologies. This is frequently observed in the elderly population, those with diabetes, or arterial hypertension for example, where new pharmaceutical developments will be needed.
This Research Topic aims to provide readers with state-of-the-art theory and practical information on oral care perspectives that determine the uptake of technological innovations and pharmacological research in dental care. The study of new topical drugs, for example non-antibiotic antibacterials, for the treatment of oral tissues in the post-surgical phase, will represent a new topic of research in dentistry for example.
This Research Topic welcomes studies and Reviews that consider the perspectives of dentistry on diagnostic and therapeutic innovations for oral disease. All oral diseases can be addressed. The goal of this issue is to provide an overview of what it takes, starting with the diagnosis, to establish therapeutic approaches that improves quality of life and quality of oral care.
In this Research Topic, we welcome manuscripts covering the below Topics within the context of pharmacology research, but not limited to:
- Autoimmune diseases of the oral cavity
- Inflammation (periodontitis) and oral diseases
- The role of human and oral microbioma in oral diseases
As a result of the aging population worldwide, the number of people who need oral care has substantially increased. At the same time, the presence of systemic diseases forms a significant challenge for oral health care. The lengthening of the average life and the proportional increase of the elderly population has determined an increase in systemic diseases and polypathology. Pharmaceutical development is, on the one hand, strongly related to these changes. Therefore, developing good oral health (including better motivation, attitude or behavior) and positive host environmental factors through multidisciplinary cooperation will be of great help in enhancing the prevention and treatment outcome of oral disease, and significantly improve the quality of life. With the increasing elderly population, the treatment of oral diseases will also require new drugs, particularly for the treatment of oral manifestations of systemic pathologies. This is frequently observed in the elderly population, those with diabetes, or arterial hypertension for example, where new pharmaceutical developments will be needed.
This Research Topic aims to provide readers with state-of-the-art theory and practical information on oral care perspectives that determine the uptake of technological innovations and pharmacological research in dental care. The study of new topical drugs, for example non-antibiotic antibacterials, for the treatment of oral tissues in the post-surgical phase, will represent a new topic of research in dentistry for example.
This Research Topic welcomes studies and Reviews that consider the perspectives of dentistry on diagnostic and therapeutic innovations for oral disease. All oral diseases can be addressed. The goal of this issue is to provide an overview of what it takes, starting with the diagnosis, to establish therapeutic approaches that improves quality of life and quality of oral care.
In this Research Topic, we welcome manuscripts covering the below Topics within the context of pharmacology research, but not limited to:
- Autoimmune diseases of the oral cavity
- Inflammation (periodontitis) and oral diseases
- The role of human and oral microbioma in oral diseases
Keywords: Oral surgery, oral biology, implant dentistry, periodonal disease, oral pharmacology
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
